IPL therapy is mainly indicated for Meibomian gland dysfunction. These glands, located at the edge of the eyelids, produce the lipid component of tears, which is essential for limiting evaporation and maintaining adequate eye hydration.
The treatment is intended for patients with:
- Evaporative dry eye
- Chronic posterior blepharitis
- Ocular rosacea
- Periorbital telangiectasia
- Recurrent styes
IPL therapy is used to stimulate these glands, restore their normal function and reduce inflammation. This improves the composition of tears and, as a result, the patient's quality of life by reducing redness and the feeling of grit in the eye, improving comfort when using screens and computers, and reducing the need for artificial tears.
IPL treatment is tailored to specific types of dry eye based on a preliminary study conducted by an ophthalmologist specialising in the cornea.